TELA Bio, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+18.2% +$3M
$21M
Cost of Revenue↑+10.8% +$686K
$7M
Gross Profit↑+22.6% +$3M
$14M
R&D↑+4.9% +$100K
$2M
D&A↓-24.0% -$41K
$130K
Operating Income↑+19.3% +$2M
$-8M
EBITDA↓-24.0% -$41K
$130K
Interest Expense↑+27.6% +$354K
$2M
Other Income/Expense↓-54.9% -$185K
$152K
Pretax Income↑+17.1% +$2M
$-9M
Tax Provision
$145K
Net Income↑+17.1% +$2M
$-9M
Gross Margin↑+2.3pts
65.9%
Operating Margin↑+12.9pts
-36.5%
Net Margin↑+13.1pts
-41.6%
Effective Tax Rate
0.0%
Deferred Tax Assets
$92K
ETR (Continuing Operations)↓-1.0pts
-0.6%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-13.2pts
-0.7%
Operating Lease Cost↑+0.0% +$0
$300K
Revenue YoY Variation↑+14.4pts
18.2%
Income YoY Variation↑+11.3pts
19.3%
Revenue QoQ Variation↑+7.8pts
0.9%
Income QoQ Variation↓-2.2pts
16.8%